- Joined
- Apr 22, 2007
- Messages
- 22,315
- Reaction score
- 8,963
http://video.foxnews.com/v/3759685896001/surgical-black-box-in-the-works/#sp=show-clips
Do you think this will ever happen in the USA?
Do you think this will ever happen in the USA?
If it were only used for learning and improvement it could be useful.
It won't be used only for learning and improvement. It's main use will be for punishment. The lawyers will want access to it. The hospital administrators will use it for sham proceedings in getting rid of "disruptive physicians". Medicare and other payors will use it to lower the payments they make to you.
What are the benefits of anesthesia SCIP measures?
1. Antibiotics 1 hour before incision? Had not been proven to make a difference in infection rates, but I bet we have much more antibiotic resistance now. And why exactly 1 hour, and not 61 minutes?
2. Preop beta-blockers? Sure, anesthesiologists are idiots and they would not give a BB if needed. Oh, wait, starting a BB periop actually worsens outcomes? And, oops, BB increase the rate of strokes? Deep thinkers these people are.
3. Periop temperature management? Suuuure, because temperature is not a standard ASA monitor, right? And we would just let our patients freeze to death, otherwise, since hypothermia is so good for their coagulation, heart and mental status.
But, hey, what can one expect from something called The Joint Commission?
Making sure and documenting that The Joint Commission's "standards" are followed is probably 5% of the cost of healthcare in the USA. "Quality" is transforming into quantity; 77% of the hospitals are now "accredited" with no significant difference in outcomes. But I guess bureaucrats excel mostly at inventing new reasons for their own existence.ASA said:ASA Standards, Guidelines and Statements provide guidance to improve decision-making and promote beneficial outcomes for the practice of anesthesiology. They are not intended as unique or exclusive indicators of appropriate care. The interpretation and application of Standards, Guidelines and Statements takes place within the context of local institutions, organizations and practice conditions. A departure from one or more recommendations may be appropriate if the facts and circumstances demonstrate that the rendered care met the physician's duty to the patient.
Standards provide rules or minimum requirements for clinical practice. They are regarded as generally accepted principles of patient management. Standards may be modified only under unusual circumstances, e.g., extreme emergencies or unavailability of equipment.
Guidelines are systematically developed recommendations that assist the practitioner and patient in making decisions about health care. These recommendations may be adopted, modified, or rejected according to clinical needs and constraints and are not intended to replace local institutional policies. In addition, practice guidelines are not intended as standards or absolute requirements, and their use cannot guarantee any specific outcome. Practice guidelines are subject to revision as warranted by the evolution of medical knowledge, technology, and practice. They provide basic recommendations that are supported by a synthesis and analysis of the current literature, expert opinion, open forum commentary, and clinical feasibility data.
Statements represent the opinions, beliefs, and best medical judgments of the House of Delegates. As such, they are not necessarily subjected to the same level of formal scientific review as ASA Standards or Guidelines. Each ASA member, institution or practice should decide individually whether to implement some, none, or all of the principles in ASA statements based on the sound medical judgment of anesthesiologists participating in that institution or practice.
POISE was just the beginning: http://www.medscape.com/viewarticle/808775What study are you basing #2 on? The POISE trial? Hm.
The ESC guidelines, along with the 2009 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) class IIa indication for patients undergoing vascular surgery[3], are based, in part, on data from the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo (DECREASE) studies. Dr Don Poldermans, formerly of Erasmus Medical Center, was best known for his work in using beta-blockers in surgery patients and published the first DECREASE paper in 1999 on the use ofbisoprolol. He also authored subsequent DECREASE studies, including DECREASE IV , which addressed the perioperative use of beta-blockers.
As has been reported extensively by heartwire and other media outlets, Poldermans was fired for violations of academic integrity and resigned from the ESC Committee for Practice Guidelines . Subsequent investigations into his research have questioned the validity of his findings, particularly the DECREASE studies. Complicating the whole matter further, Poldermans chaired the 2009 ESC guidelines for perioperative management in noncardiac surgery.
As a result of the 2008 meta-analysis, the ACCF/AHA downgraded the recommendations from class I to IIa
2. Preop beta-blockers? Sure, anesthesiologists are idiots and they would not give a BB if needed. Oh, wait, starting a BB periop actually worsens outcomes? And, oops, BB increase the rate of strokes? Deep thinkers these people are.
Even so, the "beta blocker given within 24 hours" standard applies also to patients who take their BB every 12 hours.
Another arbitrary measure, like the antibiotics within exactly 60 minutes before incision.
If something like that is to be measured, it will by definition be arbitrary. The best level of evidence we have for these sort of things is expert opinion. I doubt there will ever be a study powered well enough to differentiate between antibiotics 45 minutes before incision or 90 minutes before incision.
It's mildly painful to deal with, but it's what we are stuck with. There is no undoing it.
I actually went to a great talk by Clif Ko (head of NSQIP) where he talked about how a lot of the current quality measurement we do is ridiculous, and how a lot of hospitals have hired entire task forces to try and get their SCIP compliance from a lowly 98% to 100% and how there is both inadequate evidence for these guidelines and a massive ceiling effect. Talked about how we need better metrics and better measurements to actually define quality of care.
What are the benefits of anesthesia SCIP measures?
1. Antibiotics 1 hour before incision? Had not been proven to make a difference in infection rates, but I bet we have much more antibiotic resistance now. And why exactly 1 hour, and not 61 minutes?
Instead, I see it given for the most trivial interventions. Let's not count the number of clean lap choles, arthroscopies, breast and trivial surgeries receiving Abx, at the surgeon's whim, when they are clearly not indicated. Nobody gets punished for that. For every surgical infection we prevent (as we should), we risk creating a good number of resistant organisms (by giving Abx left and right). Why? Because people are punished for not giving Abx, but they are not for giving them when or how they shouldn't.Preoperative antibiotics are warranted if there is high risk of infection or if there is high risk of deleterious outcomes should infection develop at the surgical site (such as in the setting of immune compromise, cardiac surgery, and/or implantation of a foreign device).
Norway's model is surprisingly straightforward.
Haug unlocks the dispensary, a small room lined with boxes of pills, bottles of syrups and tubes of ointment. What's here? Medicines considered obsolete in many developed countries. What's not? Some of the newest, most expensive antibiotics, which aren't even registered for use in Norway, "because if we have them here, doctors will use them," he says.
- Norwegian doctors prescribe fewer antibiotics than any other country, so people do not have a chance to develop resistance to them.
- Patients with MRSA are isolated and medical staff who test positive stay at home.
- Doctors track each case of MRSA by its individual strain, interviewing patients about where they've been and who they've been with, testing anyone who has been in contact with them.
He points to an antibiotic. "If I treated someone with an infection in Spain with this penicillin I would probably be thrown in jail," he says, "and rightly so because it's useless there."
Convenience stores in downtown Oslo are stocked with an amazing and colorful array — 42 different brands at one downtown 7-Eleven — of soothing, but non-medicated, lozenges, sprays and tablets. All workers are paid on days they, or their children, stay home sick. And drug makers aren't allowed to advertise, reducing patient demands for prescription drugs.
In fact, most marketing here sends the opposite message: "Penicillin is not a cough medicine," says the tissue packet on the desk of Norway's MRSA control director, Dr. Petter Elstrom.
Wasn't it metoprolol that was the adverse BB culprit? I thought I remembered reading better outcomes with atenolol. But still, I agree with the sentiment, FFP.